Globoid Cell Leukodystrophy
Showing 26 - 50 of >10,000
Evaluation of Outcome Metrics in Alexander Disease
Recruiting
- Alexander Disease
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Aug 29, 2022
Macrophages Activation Pattern in X-linked Adrenoleukodystrophy,
Recruiting
- Adrenoleukodystrophy
- +3 more
- Blood sample collection
-
Le Kremlin-Bicêtre, France
- +1 more
Oct 10, 2022
Adrenoleukodystrophy, Metachromatic Leukodystrophy, Globoid Cell Leukodystrophy Trial in Minneapolis (Stem Cell Transplant,
Completed
- Adrenoleukodystrophy
- +10 more
- Stem Cell Transplant
- Busulfan, Cyclophosphamide, Antithymocyte Globulin
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Dec 3, 2017
Metachromatic Leukodystrophy (MLD) Trial in Hvidovre (rhASA - Dose Level 1, rhASA - Dose Level 2, rhASA - Dose Level 3)
Completed
- Metachromatic Leukodystrophy (MLD)
- rhASA - Dose Level 1
- +2 more
-
Hvidovre, DenmarkRigshospitalet
Jun 23, 2021
LeukoSEQ: Whole Genome Sequencing asFirst-Line Diagnostic Tool
Recruiting
- Leukodystrophy
- White Matter Disease
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Sep 13, 2022
Vasculopathy, Retinal, With Cerebral Leukodystrophy, Cerebroretinal Vasculopathy, Hereditary Trial in Saint Louis (aclarubicin)
Completed
- Vasculopathy, Retinal, With Cerebral Leukodystrophy
- Cerebroretinal Vasculopathy, Hereditary
-
Saint Louis, MissouriWashington University School of Medicine
Nov 17, 2020
Metachromatic Leukodystrophy Study (HOME Study)
Recruiting
- Metachromatic Leukodystrophy
-
Danbury, ConnecticutNational Organization for Rare Disorders
Oct 28, 2021
Metachromatic Leukodystrophy Trial in Le Kremlin-Bicêtre (intracerebral administration of AAVrh.10cuARSA)
Active, not recruiting
- Metachromatic Leukodystrophy
- intracerebral administration of AAVrh.10cuARSA
-
Le Kremlin-Bicêtre, FranceBicêtre Hospital - Paris Sud
Jan 10, 2022
Children With Metachromatic Leukodystrophy
Terminated
- Lipid Metabolism Disorders
- +13 more
-
Torrance, California
- +13 more
Mar 16, 2021
Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy
Not yet recruiting
- X-linked Adrenoleukodystrophy
- brainQuant module of brainTale-care platform
- (no location specified)
Jun 12, 2023
Biomarker for Metachromatic Leukodystrophy (BioMeta) Disease
Active, not recruiting
- Peripheral Neuropathy
- Muscle Weakness
-
Cairo, Egypt
- +4 more
May 12, 2021
Mucopolysaccharidosis, Hurler Syndrome, Hunter Syndrome Trial in Minneapolis (Campath-1H, Cyclophosphamide, Busulfan)
Completed
- Mucopolysaccharidosis
- +12 more
- Campath-1H
- +5 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Jan 9, 2018
Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)
Not yet recruiting
- Hematopoietic Stem Cell Transplantation
- Hematologic Malignancy
- CliniMACS®
- (no location specified)
Oct 17, 2023
T Lymphoblastic Leukemia/Lymphoma Trial in Hangzhou (Chidamide)
Recruiting
- T Lymphoblastic Leukemia/Lymphoma
-
Hangzhou, Zhejiang, ChinaThe First Hospital of Zhejiang Medical Colleage Zhejiang Univers
Aug 7, 2023
B-cell Acute Lymphoblastic Leukemia, B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Beijing (CD19/CD22-bispecific CAR-T
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- +2 more
- CD19/CD22-bispecific CAR-T cells
-
Beijing, Beijing, ChinaLiang Wang
Oct 7, 2023
d to Reveal Heterogeneity of Secondary Hyperparathyroidism
Not yet recruiting
- Secondary Hyperparathyroidism
- Single-cell sequencing
- (no location specified)
Nov 12, 2023
Anemia, Age Problem, Ultrasonography Trial in Nîmes (transthoracic echocardiography)
Not yet recruiting
- Anemia
- +2 more
- transthoracic echocardiography
-
Nîmes, Gard, FranceCHU de Nîmes
Sep 25, 2023
Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Not yet recruiting
- Clear Cell Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2023
Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 18, 2023
Identify Barriers to Cellular Therapies for People With Plasma
Recruiting
- Multiple Myeloma
- Lecture on the role of cellular therapies in relapse/refractory multiple myeloma/RRMM
- +5 more
-
Basking Ridge, New Jersey
- +6 more
Nov 6, 2023
PET-CT Imaging in Relapsed/Refractory Acute Leukemias
Not yet recruiting
- B Cell
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 4, 2023
Peripheral T Cell Lymphoma Trial in China (CAR-T Therapy)
Not yet recruiting
- Peripheral T Cell Lymphoma
- CAR-T Therapy
-
Hefei, Anhui, China
- +7 more
Jul 31, 2023
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted
Recruiting
- Acute Myeloid Leukemia
- +3 more
- CD123 targeted CAR-NK cells
-
Taiyuan, Shanxi, ChinaShanxi Bethune Hospital
Aug 28, 2023
Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)
Recruiting
- Renal Cell Carcinoma
- 68Ga-NY104 PET/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Jun 5, 2023
Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 25, 2023